Cargando…
The effectiveness and safety of direct-acting antivirals for hepatitis C virus treatment: A single-center experience in Saudi Arabia
BACKGROUND: The introduction of direct-acting antivirals (DAA) to treat the hepatitis C virus (HCV) overcame many drawbacks of interferon-based therapy. DAA achieved sustained viral response (SVR) rates above 90% and overcame many drawbacks of pegylated interferon regimens.The HCV genotype (GT) dist...
Autores principales: | Alarfaj, Sumaiah J., Alzahrani, Abdullah, Alotaibi, Anfal, Almutairi, Malak, Hakami, Mashael, Alhomaid, Njood, Alharthi, Noori, Korayem, Ghazwa B., Alghamdi, Abdullah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649346/ https://www.ncbi.nlm.nih.gov/pubmed/36387341 http://dx.doi.org/10.1016/j.jsps.2022.07.005 |
Ejemplares similares
-
Patients, Prescribers, and Institutional Factors Associated with Inappropriate Use of Acid Suppressive Therapy in Medical Wards: An Experience of a Single-Center in Saudi Arabia
por: Korayem, Ghazwa B, et al.
Publicado: (2021) -
Lifestyle Assessment of Primary Healthcare Physicians in Taif, Saudi Arabia in the Year 2022
por: Alamri, Abdullah S, et al.
Publicado: (2023) -
Attitudes and Preparedness of Non-Frontline Physicians in Saudi Arabia Toward the COVID-19 Pandemic
por: Malaekah, Haifaa, et al.
Publicado: (2021) -
Cost of cardiovascular diseases and renal complications in people with type 2 diabetes mellitus in the Kingdom of Saudi Arabia: A retrospective analysis of claims database
por: Al-Jedai, Ahmed Hamden, et al.
Publicado: (2022) -
Evaluation of Side Effects Associated with COVID-19 Vaccines in Saudi Arabia
por: Alhazmi, Abdulaziz, et al.
Publicado: (2021)